Recent clinical studies surrounding the medication Retatrutide , specifically the 120 milligram formulation branded as ZPHC, suggest a impressive benefit on weight loss and linked metabolic factors. Experts posit that this combined agonist , targeting both GLP-1 and GIP receptors , may represent